VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor
AssigneeTufts University
InventorCharles B. Shoemaker
Life of this patent
Estimating the term…
Abstract
Methods, compositions and kits are provided for treating a subject exposed to or at risk for exposure to a disease agent, methods, compositions and kits having a pharmaceutical composition including at least one recombinant binding protein or a source of expression of the binding protein, wherein the binding protein neutralizes at least one or a plurality of disease agents that are toxins, for example at least one of a Botulinum toxin or an Anthrax toxin.
Claims7
A recombinant binding protein that specifically binds to a Bacillus anthracis toxin, wherein the binding protein comprises an amino acid sequence selected from SEQ ID NO:
- 81, SEQ ID NO:
- 93, SEQ ID NO:
- 13, SEQ ID NO:
- 1, SEQ ID NO:
- 3, SEQ ID NO:
- 5, SEQ ID NO:
- 7, SEQ ID NO:
- 9, SEQ ID NO:
- 11, SEQ ID NO:
- 15, SEQ ID NO:
- 103, SEQ ID NO:
- 105, or a combination thereof.
Dependencies are inferred from the claim text.